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Abstract
Inflammatory myofibroblastic tumour (IMT) is an uncommon mesenchymal tumour, which can occur anywhere
in the body, rarely in esophagus. Mostly, the diagnosis is postoperative, after the hispathological evaluation of
the specimen. There are no definite guidelines regarding the diagnosis and management. Here, we report a
60 year old lady presenting with dysphagia, diagnosed to have a submucosal esophageal tumor with Barium
esophagogram and contrast enhanced computed tomography. She was managed successfully with surgical
enucleation with the final histopathological diagnosis of IMT. Surgical excision is not only therapeutic but also
diagnostic in such cases.
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Background
Inflammatory myofibroblastic tumor (also known as
plasma cell granuloma) is a rare mesenchymal tumor.
It is a distinctive lesion composed of myofibroblastic
spindle cells with an inflammatory infiltrate of plasma
cells, lymphocytes, and eosinophils. It occurs most
commonly in the lungs and uncommonly in the sites
such as brain, trachea, breast, spleen, kidneys, liver,
stomach and the ampulla of Vater. It is extremely
rare in the esophagus and there are very few cases of
esophageal IMT reported in English literature till
date. It is seen mostly in children and young adults
but can occur in any age, affecting females and males
equally (female to male-1:1.4) [1].
We report an elderly female who underwent complete
excision of the esophageal IMT and is doing fine without
evidences of recurrence at follow up visits.
Case presentation
A 60 year old diabetic, non smoker, housewife presented
to us with complaints of gradual onset, progressive dys-
phagia initially for solid and later for liquid food for one
and a half year and foreign body sensation in throat for
6 months. She had lost 10 kg over last 6 months, despite
having a good appetite. She did not have significant
medical or surgical illness or intervention in the past.
General and systemic clinical examination was normal.
Her hematological and biochemical investigations were
normal too. Barium esophagogram revealed smooth
narrowing of the mid thoracic esophagus with proximal
dilatation (Fig. 1). Esophagoscopy was suggestive of a
submucosal growth with intact mucosa from 18 to
25 cm from central incisors, involving half of the
circumference of esophagus, located at 12 to 6 o’ clock
position (Fig. 2). Contrast enhanced computed tomog-
raphy (CECT) scan of neck, chest and abdomen revealed
a longitudinally oriented, well defined, non-enhancing,
homogenous lesion involving the lower cervical and
upper thoracic esophagus, causing significant luminal
narrowing (Fig. 3). The patient underwent a right lateral
thoracotomy. Esophageal dissection was done and longi-
tudinal incision was made in the esophagus, over the
lesion which was deepened through the muscle layer
and enucleation of the lesion was performed. It was a
solid, submucosal mass measuring 8.5 × 6 × 2.5 cm
(Fig. 4). While dissecting the mass out, there was a 6 cm
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long clear rent in the mucosa but as the tissue was
healthy, uninflamed and well vascularised, it was pri-
marily repaired in two layers and reinforced with
adjacent pleural flaps. She was kept on partial paren-
teral nutrition, intravenous Pantoprazole, nasogastric
drainage and enteral feeding was done through feed-
ing jejunostomy. Contrast esophagogram on seventh
postoperative day revealed normal esophagus (Fig. 5).
She was started on liquid diet initially and later she
could swallow both solid and liquid food without
dysphagia. She was discharged from hospital on tenth
postoperative day. Gross pathology demonstrated an
encapsulated solid mass with cut surface showing
solid white areas without hemorrhage, necrosis and
calcification. The microscopic examination of the mass
revealed proliferation of spindle cells with stroma of pro-
liferative blood vessels and lymphoplasmacytic infiltration
with formation of lymphoid follicles (Fig. 6). The cells
were immunonegative for Anaplastic Lymphoma Kinase
(ALK). The patient is on regular follow up. At 6 months
postoperatively she is doing well, without recurrence of
her symptoms. Esophagoscopy done revealed normal
esophagus.
Discussion
The etiology of IMTs is supposed to be an aberrant
response to tissue injury with myofibroblast being the
primary cell type [2]. The commonly reported etiologies
of IMTs include Epstein Barr virus, human herpes virus
eight infection, trauma, reflux and overexpression of
interleukin 6 [3, 4]. IMT, although once thought to be
benign, is now considered to be an intermediate-grade
tumor with potential for recurrence [5]. The most fre-
quent symptoms of IMTs of the esophagus are dysphagia
(as in our patient), substernal pain and inflammatory
features related to cytokine release like fever, weight loss
and raised acute phase reactants. Interestingly, the latter
features were absent in our patient. Endoscopic Ultra-
sound (EUS) is the diagnostic test of choice, which can
show hypoechoic lesion of the muscularis propria. But
EUS characterization and final pathology are correlated
in only 77 % of cases [6]. However, other investigation
modalities can be of substantial help in diagnosing the
condition. A chest X-ray can demonstrate a peri-hilar
shadow if the tumour is big enough. Barium swallow
may demonstrate smooth tapering and an even filling
defect in the esophagus [7]. Esophagoscopy usually shows
a submucosal growth similar to that of leiomyoma. CECT
scan demonstrates a homogenous soft tissue lesion in the
esophagus [8]. Our patient demonstrated all the features
on corresponding investigations. The differential diag-
noses of IMTs include other submucosal lesions like leio-
myoma and gastrointestinal stromal tumours. Esophageal
IMTs are found most commonly in the thoracic portion,
Fig. 1 Barium swallow: arrow head showing smooth narrowing of
the mid esophagus
Fig. 2 Esophagoscopic picture: arrow head showing the esophageal
submucosal growth with an intact mucosa
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followed by cervical and the distal esophagus [9]. These
generally appear as small nodules or circumscribed masses
and are frequently associated with mucosal ulceration.
However the tumour can range from 1.5 to 20 cm in
length [10]. Grossly, these are firm tumours composed of
spindle shaped myofibroblastic cells with plasmacytic infil-
tration. The cells are immunopositive for vimentin, smooth
muscle actin and immunonegative for CD34, CD117, and
S100 [1]. More than 50 % of IMTs are reactive for ALK
protein. Although ALK reactivity is not specific to
IMT, it appears to be a factor associated with metas-
tasis and recurrence [11]. Surgery is the treatment of
choice, with esophagotomy and enucleation being the
commonest procedure. However there are reports of
such cases being managed by observation, medical man-
agement with proton pump inhibitors, esophagectomy,
Fig. 3 CT images: arrow showing the esophageal mass
Fig. 4 Esophageal mass
Fig. 5 Postoperative gastrograffin swallow: normal caliber esophagus
with no contrast extravasation
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endoscopic resection and chemotherapy and radiation
(in large, unresectable tumours). Prognosis is favourable
without recurrence in the majority of the cases.
Conclusion
Although esophageal IMT is an extremely rare entity, it
should always be considered a differential diagnosis in a
patient presenting with dysphagia and submucosal eso-
phageal tumour. The complete excision of the tumour is
not only therapeutic but also helps to confirm the diag-
nosis with histopathological examination and immuno-
histochemistry. As it is an intermediate grade tumour
with recurrence potential, patient should be followed up
regularly.
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Fig. 6 Microscopic study: slide showing plasmacytic infiltration
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